Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riociguat in Raynaud's Phenomenon
NCT01926847Phase 2Completed
- Sponsor
- Bayer
- Start
- Oct 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of riociguat in Raynaud phenomenon, sponsored by Bayer. Started Oct 2013; status: completed.
02
Drugs
riociguat
03
Conditions
Raynaud phenomenon
Beyond the preview
Go deeper on NCT01926847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01926847.